Venture Market July 23, 2026: CuspAI's $450M Round at $2.6B Valuation, Neo Emerges from Stealth with $100M, Deals from Natural, Empirical Security, Infinity, Brenus Pharma, and Plazza, Analysis on Capital Shift in AI Control Layer for Venture Investors and Funds
Key Topic of the Day: The venture market has shifted from paying for access to models to paying for control over the bottlenecks surrounding them. CuspAI's $450M round at a $2.6B valuation, Neo's stealth emergence with $100M, and a wave of strategic investments from corporations and private equity are forming a new logic of capital distribution. We explore what this means for venture funds and LPs.
Venture investments in mid-July 2026 are not widely distributed across the startup market. Capital is clearly shifting towards infrastructure, security, and software that resides in the AI control layer, rather than in the presentation layer. The largest check of the cycle went to AI material development, while other notable rounds clustered around cybersecurity, inference software, payment rails for AI agents, and automation of regulated workflows.
This combination is significant for investment committees. It indicates that funds still want exposure to AI but increasingly prefer businesses that shape the computation economy, control data, or manage critical corporate processes, rather than another thin enhancement on a frontier model.
Deal of the Day: CuspAI Raises $450M at $2.6B Valuation
The Series B round for Britain's CuspAI was a defining transaction of the week, indicating where deep-pocketed investors see the next protective moat in AI—not only in the models but also in the physical systems that these models help design.
- Round Size: $450M, Series B, $2.6B valuation.
- Syndicate: Led by Kleiner Perkins and NEA, with participation from Bezos Expeditions, the UK government, AMD Ventures, Lux Capital, Glade Brook Capital Partners, and Invest-NL.
- Total Funding: Over $650M in just two years since launch.
- Headquarters: Cambridge, UK.
The company utilizes AI to discover new materials, focusing on semiconductors, batteries, clean energy, and advanced manufacturing. Investors are interested in the fact that materials are positioned upstream in several constrained markets. If AI can reduce semiconductor production's dependence on rare metals, shorten R&D cycles, or improve energy materials, the returns extend beyond software multiples—they cascade into manufacturing economics, supply chain resilience, and geopolitical competitiveness.
The lesson for founders is harsh: such a level of capital intensity in deep tech is only financed when the project is tied to strategic industrial demand, rather than abstract scientific promise.
Cybersecurity as a Magnet for Venture Capital
The second major cluster of deals is cybersecurity, and this is no coincidence. AI is not just creating new software categories; it is rewriting the risk model for already existing ones.
Neo: $100M Emerging from Stealth
Boston-based Neo raised $100M through a combined seed and Series A round led by Andreessen Horowitz, Bessemer Venture Partners, Craft Ventures, and Merlin Ventures. The company was founded by former SentinelOne executives Nick Warner and Shlomi Salem, along with technologist Eran Shirazi. The thesis is straightforward: traditional corporate security tools are poorly adapted to the world of AI applications and agent systems. The platform allows security teams to see, validate, and control AI software before access to data or automated actions create new operational risks. The technology is already undergoing pilots in finance, energy, and transportation.
Empirical Security: $25M Predicting Exploited Threats
The Chicago-based company raised its Series A led by Brightmind Partners, with participation from HPA and Costanoa Ventures, bringing total funding to $37M. Their positioning is noteworthy: instead of broad rhetoric on "AI security," the company focuses on predicting threats through monitoring exploited vulnerabilities. Budgets open up faster for software that helps prioritize specific vulnerabilities than for platforms promising simply "more intelligence."
Second Order AI Stack: Software that Makes Hardware Useful
The seed round for Infinity at $15M with a post-money valuation of $100M deserves particular attention from venture investors. The company is building a software layer that enables any AI chip to be inference-ready.
The investment thesis here is simple: new chips don't matter if developers can't rapidly deploy on them. Nvidia's dominance in AI is due more to software and ecosystem maturity than just hardware performance. Infinity is essentially selling time to usefulness: if new silicon manufacturers can become inference-ready in days instead of months or years, they stand a chance of competing for manufacturing demand.
A deeper signal is that venture capital is seriously investing in the "second order AI stack." The market has already spent vast sums on model developers and chip companies. The next money flows to translators, adapters, and orchestration layers that make this infrastructure usable.
Agent Commerce: Payment Rails for AI
Startup Natural closed a Series A round of $30M led by Kirsten Green of Forerunner, bringing total funding to $40M. The company addresses a challenge that will grow with every viable agent scenario: how software executes financial actions on behalf of a user or company without causing chaos in access rights, payment friction, and compliance issues.
The logic for investors is clear:
- Agent commerce is easy to demonstrate but difficult to scale into production.
- Once software starts buying software, paying suppliers, and processing transaction processes, the product becomes the rails themselves.
- The owner of this layer captures volume, compliance, and embedded distribution far beyond what thin applications can achieve.
This provides the company with a more resilient position than many applied AI startups, whose differentiation blurs as foundational models improve. For founders, the difference is fundamental: AI that saves a click will struggle to attract; AI that safely moves a dollar attracts strategic capital.
The Return of Strategic Capital: PE, Corporations, and Distribution Channels
One of the most telling features of the current market is that a notable share of strategically significant funding has come not from traditional venture funds but from private equity, corporate, and ecosystem partners.
- Quorum (Washington) received an undisclosed strategic investment from Enlightenment Capital. The AI-based platform for government affairs serves over 2000 organizations, including more than half of Fortune 100 companies. The capital is aimed at executing the product roadmap and expanding agent AI capabilities.
- Wagmo (New York) secured a strategic investment from Curql to bring modern veterinary health insurance to the credit union channel—a prime example of distribution-oriented capital.
- HALO X-ray Technologies (Nottingham, UK) closed a multimillion-dollar round led by Agilent with participation from the UK Innovation Science Seed Fund and Midland Engine Investment Fund to complete regulatory approval for x-ray diffraction technology in screening systems.
When buyers, channels, or industry experts can finance part of the next chapter of growth, founders become less dependent on purely financial sponsors. In a tougher capital market, this is an advantage.
Biotech and Healthcare: Funding Linked to Milestones, Not Narratives
Lyon-based Brenus Pharma added €11M to its Series A round, bringing total funding since inception to €38M. The extension is tied to achieving clinical, regulatory, and business development milestones surrounding STC-1010—the leading clinical immunotherapy program for stomach and colorectal cancer. The company also noted the arrival of new investors from Europe and the Asia-Pacific region.
Such extensions are important indicators of risk underwriting. Instead of pressuring every company into a new narrative reset, investors are willing to add capital when the team has sufficiently de-risked the science. This is often healthier than a completely new round at an inflated valuation, as it directly ties capital to progress.
In India, Plazza (Bengaluru) raised $15M in a Series A led by Accel, Elevation Capital, and Nexus Venture Partners for the expansion of its pharmacy network and instant medication delivery. This is a bet on logistics and trust in a category where reliability is more important than brand storytelling: availability, order fulfillment rate, inventory routing, and area coverage density create a true protective moat.
Geography of Capital: A Market Without a Single Template
The current venture landscape is geographically mixed but uneven:
- USA dominates early-stage software and cybersecurity—Neo, Empirical Security, Infinity.
- UK received the largest check of the cycle through CuspAI and demonstrated strength in deep tech with the involvement of government capital.
- France emerged through biotech and clinically validated assets.
- India entered the agenda through operationally dense commerce in healthcare, rather than frontier AI.
Global venture does not converge into one template. Different regions attract capital where they already have talent density, regulatory competence, or operational advantage.
The Cycle Risks: Where Venture Funds May Overpay
The discipline of the current market does not erase structural threats to portfolios:
- Risk of Commoditization. AI applications built on widely accessible models may grow, but sustainable money is shifting below or around the model layer.
- Uneven Disclosure. A significant portion of strategically interesting transactions occurs without disclosing amounts, complicating benchmark assessments.
- Capital Intensity of Deep Tech. Computing, lab processes, and industrial partnerships are costly, leading to continuous dilution of early investor stakes.
- Concentration in Narrow Categories. When the market primarily pays for infrastructure, security, and science, the correlation of risks within the portfolio increases.
- Dependence on Regulatory Milestones. In biotech and physical security, approval timelines remain a major source of uncertainty.
Takeaways for Venture Investors and Funds
The current deal flow shows a market attempting to value not novelty but where AI is creating sustainable scarcity. In some cases, this is a scarce scientific competence, as seen with CuspAI. In others, it is a scarcity of trust, as in cybersecurity and public policy software. In yet others, it's a scarcity of operational reliability, as seen in drug delivery.
Practical takeaways for investment committees:
- Finance Bottlenecks, Not Slogans. If a startup touches upon infrastructure cost, security state, compliance processes, or high-frequency order fulfillment, large rounds are still underwritten.
- Look for Accumulating Security. Scientific intellectual property and industrial partnerships, founder reputations, ecosystem leverage, and progress on scientific milestones—these are the common denominators, not technology, but the ability to make a replacement painful.
- Consider the Type of Investor as a Value Factor. Sometimes the most valuable investor is not the one paying the highest price but the one opening the most cost-effective and secure route to customers.
- Ask What Changes with the Next Dollar. Extensions, strategic investments, and concentrated early rounds are crowding out broad syndication based on hype—both sides of the market are becoming more disciplined.
- Bet on Layers Around Autonomy. Payments, security, chips, science, and workflow infrastructure benefit from AI while remaining hard to commoditize. This is where premium multiples are likely to concentrate.
The next phase of startup financing looks less like a race to bolt AI onto everything and more like a competition for ownership of the systems that make AI safe, deployable, and economically useful. Companies winning capital now are not just promising automation—they are defining who controls the bottlenecks around it.
